Sector Alpha

Track where the smart money flows in Indian equities

DashboardWeekly UpdateUploadPipelinePE CyclesBrainAbout

Data updated weekly. Not financial advice.

Sector Alpha
  1. Home
  2. /Momentum
  3. /Medical Equipment
  4. /Hemant Surgical Industries Ltd
MomentumDeep Value

Hemant Surgical Industries Ltd: Why Is It Outperforming Nifty 500?

Active
RS +46.4%WeakNew This Week

In Week of May 17, 2026, Hemant Surgical Industries Ltd (Medical Equipment) is outperforming Nifty 500 with +46.4% relative strength. Fundamentals: Weak.

Hemant Surgical Industries Ltd Key Facts

PE Ratio
29.2x
Market Cap
₹532 Cr
PAT Growth YoY
+160%
Revenue Growth YoY
+188%
OPM
9.0%
RS vs Nifty 500
+46.4%
Avoid

What's Happening

🚫No earnings growth, no valuation discount — limited upside
📊Debt increased 61% YoY — leverage rising
👔Promoter stake down 14.7% this quarter
🏛️DII accumulation — stake up 9.7%

Key Numbers

PAT Growth YoY
+160%
Insufficient Data
Revenue YoY
+188%
Insufficient Data
Operating Margin
9.0%
0 bps YoY
PE Ratio
29.2
Current Price
₹408
Fundamental Score
37/100
Weak
3Y PAT CAGR
+80%
Market Cap
532 Cr
Valuation
N/A

12-Week Performance

Weekly presence in the outperformers list. Green = beating Nifty 500 by 10%+ that week.

12 weeks agoThis week

How Fast Is Hemant Surgical Industries Ltd Growing?

Revenue, profit and margin growth rates

MetricYoY3Y CAGRTrend
Revenue+188%+80%Insufficient Data
PAT (Net Profit)+160%+80%Insufficient Data
OPM9.0%0 bpsInsufficient Data
← Back to Medical EquipmentDashboard

Frequently Asked Questions: Hemant Surgical Industries Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Hemant Surgical Industries Ltd's latest quarterly results?

Hemant Surgical Industries Ltd's latest quarterly results (Mar 2026) show

  • PAT Growth YoY: +160.0% (insufficient_data)
  • Revenue Growth YoY: +187.9%
  • Operating Margin: 9.0% (insufficient_data)

Is Hemant Surgical Industries Ltd's profit growing or declining?

Hemant Surgical Industries Ltd's profit is growing with an insufficient_data trend.

  • PAT Growth YoY: +160.0% (latest quarter)
  • PAT Growth QoQ: +160.0% (sequential)
  • 3-Year PAT CAGR: +80.0%
  • Trend: Insufficient_data — consistent growth pattern

What is Hemant Surgical Industries Ltd's revenue growth trend?

Hemant Surgical Industries Ltd's revenue growth trend is insufficient_data.

  • Revenue Growth YoY: +187.9%
  • Revenue Growth QoQ: +156.9% (sequential)
  • 3-Year Revenue CAGR: +80.0%

How is Hemant Surgical Industries Ltd's operating margin trending?

Hemant Surgical Industries Ltd's operating margin is insufficient_data.

  • Current OPM: 9.0%
  • OPM Change YoY: 0.0% basis points
  • OPM Change QoQ: -3.0% basis points

What is Hemant Surgical Industries Ltd's 3-year profit and revenue CAGR?

Hemant Surgical Industries Ltd's long-term compounding rates

  • 3-Year Profit CAGR: +80.0%
  • 3-Year Revenue CAGR: +80.0%

Is Hemant Surgical Industries Ltd's growth accelerating or decelerating?

Hemant Surgical Industries Ltd's earnings growth is insufficient_data with insufficient_data on a sequential basis.

  • Sequential Acceleration: +50.0% bps

What is Hemant Surgical Industries Ltd's current PE ratio?

Hemant Surgical Industries Ltd's current PE ratio is 29.2x.

  • Current PE: 29.2x
  • Market Cap: 532 Cr

What is Hemant Surgical Industries Ltd's price-to-book ratio?

Hemant Surgical Industries Ltd's price-to-book ratio is 3.9x.

  • Price-to-Book (P/B): 3.9x
  • Book Value per Share: ₹106
  • Current Price: ₹408

Is Hemant Surgical Industries Ltd a fundamentally strong company?

Hemant Surgical Industries Ltd is rated Weak with a fundamental score of 37/100. This score is calculated from objective financial metrics

  • Revenue Growth YoY: +187.9% (10% weight)
  • PAT Growth YoY: +160.0% (10% weight)
  • PAT Growth QoQ: +160.0% (10% weight)
  • Margins stable (10% weight)

Is Hemant Surgical Industries Ltd debt free?

Hemant Surgical Industries Ltd has a debt-to-equity ratio of N/A.

  • Total Debt: ₹50 Cr

What is Hemant Surgical Industries Ltd's return on equity (ROE) and ROCE?

Hemant Surgical Industries Ltd's return ratios over recent years

  • FY2026: ROCE 20.0%

Is Hemant Surgical Industries Ltd's cash flow positive?

Hemant Surgical Industries Ltd's operating cash flow is negative (FY2026).

  • Cash from Operations (CFO): ₹-32 Cr
  • Free Cash Flow (FCF): ₹-35 Cr
  • CFO/PAT Ratio: -178% (weak cash conversion)

What is Hemant Surgical Industries Ltd's dividend yield?

Hemant Surgical Industries Ltd currently does not pay a significant dividend (yield 0.00%).

  • Dividend Yield: 0.00%
  • Current Price: ₹408

Who holds Hemant Surgical Industries Ltd shares — promoters, FII, DII?

Hemant Surgical Industries Ltd's shareholding pattern (Mar 2026)

  • Promoters: 58.9%
  • FII (Foreign): 0.1%
  • DII (Domestic): 10.7%
  • Public: 30.2%

Is promoter holding increasing or decreasing in Hemant Surgical Industries Ltd?

Hemant Surgical Industries Ltd's promoter holding has remained stable recently.

  • Current Promoter Holding: 58.9% (Mar 2026)
  • Previous Quarter: 58.9% (Sep 2025)
  • Change: 0.00% (stable)

How long has Hemant Surgical Industries Ltd been outperforming Nifty 500?

Hemant Surgical Industries Ltd has been outperforming Nifty 500 for 1 consecutive week, indicating early-stage outperformance.

Is Hemant Surgical Industries Ltd a new momentum entry or an established outperformer?

Hemant Surgical Industries Ltd is a new entry this week — it just started outperforming Nifty 500. New entries are worth monitoring for follow-through.

Is Hemant Surgical Industries Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Hemant Surgical Industries Ltd may be worth studying

  • Earnings growing at +160.0% YoY

What is the investment thesis for Hemant Surgical Industries Ltd?

Hemant Surgical Industries Ltd investment thesis summary:

Research Signals (Bull Case)

  • Revenue growing at +187.9% YoY

What is the future outlook for Hemant Surgical Industries Ltd?

Hemant Surgical Industries Ltd's forward outlook based on current data signals

  • Earnings Trend: insufficient_data
  • Revenue Trend: insufficient_data
  • Margin Trend: insufficient_data

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.